StockData

Regenerative Medical Technology Group Inc. (RMTG) stock

RMTGOTCRetail-Retail Stores, NECFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 3/30
$0.04−0.00 (-5.76%)

Close on Oct 19, 2026Market cap $497.25KP/E –Yield –

How the market prices Regenerative Medical Technology

Each ratio against its own distribution since 2018, from month-end prices and the figures reported at the time

Regenerative Medical Technology trades at 0.1× its earnings, against a median of 0.6× since 2018 — cheaper than 97% of the months in between.

The shaded bar covers the 5th to 95th percentile of month-end values since 2018, the darker part the 25th to 75th, the line the median and the dot today. The figure on the right is the percentile today sits at.

Price to sales since 2018

Median 0.6×, today 0.1×

What Regenerative Medical Technology keeps of every dollar

Trailing twelve months, from revenue down to net income. Grey columns are what comes out.

Margins against the industry

Gross margin59.8%vs 39.8%
Operating margin0.46%vs -0.00%
EBITDA margin4.32%vs 1.22%
Net margin-101.2%vs -0.34%
Free cash flow margin-6.19%vs 1.51%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it earns on the capital it uses

Trailing twelve months over average capital

Return on assets-184.4%vs -2.25%

How hard the assets work

Revenue per dollar of assets1.82vs 1.46
Inventory turns a year12.91vs 5.80
Revenue per employee$9.41Mvs $406.50K
Profit per employee-$9.53Mvs -$3.25K

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Borrowings exceed cash by $676.70K, or 1.7 times a year of EBITDA.

Total debt$2.00M
Cash and short-term investments$1.32M
EBITDA, trailing twelve months$406.65K
Free cash flow, trailing twelve months-$582.33K

Leverage and liquidity

Debt to EBITDA4.92vs 2.99
Net debt to EBITDA1.66vs 0.85
Current ratio0.05vs 1.17
Quick ratio0.03vs 0.45

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Scores and rules of thumb

Academic scores computed from the latest two fiscal years. They are screens, not verdicts.

Piotroski F-Score

Nine yes-or-no tests of profit, leverage and efficiency against last year.

2 of 9 tests passed

How the shares have traded

Total return includes reinvested dividends, to the close on Oct 19, 2026

Total return against the S&P 500

The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.

RMTGS&P 500
PeriodRMTGS&P 500DifferenceRMTG per yearS&P 500 per year
1 month-52.5%+0.6%−53.1 pts
3 months-57.8%+3.4%−61.1 pts
Year to date-23.3%+13.3%−36.5 pts
1 year-31.6%+16.6%−48.2 pts
3 years+191.5%+86.4%+105.1 pts+42.8%+23.1%
5 years-65.6%+81.9%−147.5 pts-19.2%+12.7%
10 years-87.5%+318.9%−406.3 pts-18.8%+15.4%

Who is betting against it

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M RMTG shares were sold short on Oct 30, 2026, up 0.0% from the previous report. At recent volumes it would take 1.0 days to buy them back.

Shares sold shortDays to cover

The last twelve reports

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20261750.0%82,2851.0
Oct 15, 2026175-98.0%69,7251.0
Sep 30, 20268,7490.0%107,8201.0
Sep 15, 20268,749-12.6%102,4371.0
Aug 31, 202610,010+15.4%163,9171.0
Aug 14, 20268,674+8574.0%98,0021.0
Jul 31, 2026100-96.5%436,9621.0
Jul 15, 20262,826–294,8841.0
Dec 31, 20251,9490.0%16,6721.0
Dec 15, 20251,9490.0%9,7451.0
Nov 28, 20251,9490.0%1,4261.4
Nov 14, 20251,9490.0%13,7411.0

Every measure, in full

44 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
–

Share statisticsIndustry

Shares Change (YoY)
3.32%
1.66%
Shares Change (QoQ)
4.57%
0.26%
Float
14M
36M
Shares Held by Insiders
0.00%
8.38%

MarginsIndustry

Gross Margin
59.8%
39.8%
Operating Margin
0.46%
-0.00%
Profit Margin
-101.2%
-0.34%
EBITDA Margin
4.32%
1.22%
FCF Margin
-6.19%
1.51%

Returns on capitalIndustry

Return on Assets (ROA)
-184.4%
-2.25%

Financial positionIndustry

Current Ratio
0.05
1.17
Quick Ratio
0.03
0.45
Debt / EBITDA
4.92
2.99
Net Debt / EBITDA
1.66
0.85
Interest Coverage
0.00
-0.18

GrowthIndustry

Revenue Growth (YoY)
94.3%
6.39%
Revenue Growth (3Y CAGR)
49.4%
-1.38%
Revenue Growth (5Y CAGR)
147.4%
4.80%

EfficiencyIndustry

Asset Turnover
1.82
1.46
Inventory Turnover
12.91
5.80
Revenue Per Employee
$9.41M
$406.50K
Profits Per Employee
-$9.53M
-$3.25K
Employee Count
1
445

Income statement (TTM)Industry

Revenue
$9.41M
$366.90M
Gross Profit
$5.63M
$250.49M
Operating Income
$43.73K
-$128.01K
Net Income
-$9.53M
-$578.22K
EBITDA
$406.65K
$185.52K
EPS (Diluted)
-$0.75
$0.00

Balance sheetIndustry

Total Debt
$2.00M
$64.14M
Net Cash (Debt)
-$676.70K
$36.94K
Net Cash Per Share
-$0.05
$0.00
Equity (Book Value)
-$39.26M
$22.06M
Book Value Per Share
-$2.86
$0.92
Tangible Book Value
-$40.95M
$1.97M
Working Capital
-$40.33M
$2.15M

Cash flow (TTM)Industry

Operating Cash Flow
$268.56K
$1.90M
Capital Expenditures
-$850.89K
-$12.16M
Free Cash Flow
-$582.33K
$7.56M
FCF Per Share
-$0.04
$0.28

Taxes and interestIndustry

Interest Expense
$9.92M
$1.99M

Scores and fair valueIndustry

Piotroski F-Score
2
5

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?